Pharmacological treatment for connective tissue disease-associated interstitial lung involvement: Protocol for an overview of systematic reviews and meta-analyses

BACKGROUND: Interstitial lung disease (ILD) is the most important pulmonary manifestation of connective tissue diseases (CTDs) since it is associated with high morbidity and mortality. However, there is uncertainty on what constitutes the optimal treatment options from a variety of competing interve...

Descripción completa

Detalles Bibliográficos
Autores principales: Karassa, Fotini B., Bougioukas, Konstantinos I., Pelechas, Eleftherios, Skalkou, Anastasia, Argyriou, Evangelia, Haidich, Anna-Bettina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348721/
https://www.ncbi.nlm.nih.gov/pubmed/35921316
http://dx.doi.org/10.1371/journal.pone.0272327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348721/
https://www.ncbi.nlm.nih.gov/pubmed/35921316
http://dx.doi.org/10.1371/journal.pone.0272327

Ejemplares similares